GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Price-to-Operating-Cash-Flow

Nortem Biogroup (XPAR:MLBIO) Price-to-Operating-Cash-Flow : (As of Jun. 16, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Price-to-Operating-Cash-Flow?

As of today (2024-06-16), Nortem Biogroup's share price is €5.40. Nortem Biogroup does not have enough years/quarters to calculate the Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2022. Therefore GuruFocus does not calculate Price-to-Operating-Cash-Flow Ratio at this moment.

The historical rank and industry rank for Nortem Biogroup's Price-to-Operating-Cash-Flow or its related term are showing as below:

XPAR:MLBIO's Price-to-Operating-Cash-Flow is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 10.54
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Nortem Biogroup's Cash Flow from Operations per share for the six months ended in Dec. 2022 was €0.00.


Nortem Biogroup Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Nortem Biogroup's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Price-to-Operating-Cash-Flow Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
Price-to-Operating-Cash-Flow
- -

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
Price-to-Operating-Cash-Flow - -

Competitive Comparison of Nortem Biogroup's Price-to-Operating-Cash-Flow

For the Packaged Foods subindustry, Nortem Biogroup's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nortem Biogroup's Price-to-Operating-Cash-Flow Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's Price-to-Operating-Cash-Flow falls into.



Nortem Biogroup Price-to-Operating-Cash-Flow Calculation

Nortem Biogroup's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=5.40/
=

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Nortem Biogroup Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Nortem Biogroup (XPAR:MLBIO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines